Foxo Technologies to begin trading on OTC

FOXO Technologies Inc. (“FOXO” or the “Company”) announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to delist the Class A common stock of FOXO (Ticker symbol FOXO) from NYSE American, pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Class A commons stock. The share price went below the NYSE minimum price of $0.10 on August 12, 2025 and was immediately suspended from trading by NYSE.

The Company submitted an application to have its common stock traded on the OTC and has on August 12, 2025 received confirmation from FINRA’s Department of Market Operations that the trading symbol, “FOXO” has been assigned by them to the Common Stock of Foxo Technologies, Inc., and that the Company’s Common Stock may be quoted and traded on the OTC market as of August 13, 2025.

“While we are disappointed that our share price has fallen below the $0.10 minimum requirement for continued listing on NYSE, this does not change the business strategy adopted or economic outlook for FOXO,” said Seamus Lagan, Chief Executive Officer of FOXO. “We remain focused on our current business and efforts to complete acquisitions that will accelerate growth and increase shareholder value. We will consider our options and the viability to apply to list our common stock on NYSE or NASDAQ at the appropriate time. Meantime the Company will remain fully compliant with SEC reporting requirements and looks forward to demonstrating continued progress in its upcoming 10-Q to June 30, 2025.”

You May Also Be Interested In

• Tenon Medical closes $3M private placement with institutional investor
• FirstCash raises credit facility to $1.055B, extends term to 2031
• Department of War adds Starshield AI's Grok to GenAI platform